Deadly bacteria defy drugs, alarming doctors
Los Angeles Times, February 17, 2009
Acinetobacter doesn't garner as many headlines as methicillin-resistant Staphylococcus aureus, the dangerous superbug better known as MRSA. But a January report by the Infectious Diseases Society of America warned that drug-resistant strains of Acinetobacter baumannii and two other microbes could soon produce a toll to rival MRSA's. The three bugs belong to a large category of bacteria called "gram-negative" that are especially hard to fight because they are wrapped in a double membrane and harbor enzymes that chew up many antibiotics. As dangerous as MRSA is, some antibiotics can still treat it, and more are in development, experts say.
Most Viewed
Most Emailed
- Urologists 'Outraged' Over PSA Test Challenge
- Luxury Hospital Facilities Put Patient Experience First
- New Facebook Page Gathers Stories of Medical Harm
- Mapping Out Revenue-Cycle Solutions
- Will Maryland's Rate Shift Send Tremors Around the Country?
- E-book Revolution Changes, Challenges Healthcare
- How Rivals Built an ACO
- FL Hospital Vendors Sentenced in Bribery Scheme
- Heartland Health Joins Mayo Clinic Network
- Health Insurance Exchanges Put Defined Benefits to the Test

